Copyright
©The Author(s) 2016.
World J Hepatol. Jul 8, 2016; 8(19): 815-824
Published online Jul 8, 2016. doi: 10.4254/wjh.v8.i19.815
Published online Jul 8, 2016. doi: 10.4254/wjh.v8.i19.815
Patients’ characteristics | Overall population (n = 48) | Patients treated with DAAs (n = 8) |
Qualitative variables | ||
Gender | ||
Female | 25 (52) | 1 (12) |
Male | 23 (48) | 7 (88) |
HCV RNA genotype | ||
1a | 3 (6) | 0 (0) |
1b | 29 (61) | 8 (100) |
2a/2c | 4 (8) | 0 (0) |
3 | 1 (2) | 0 (0) |
4 | 2 (4) | 0 (0) |
Not available | 9 (19) | 0 (0) |
Quantitative variables, median (range) | ||
Age (yr) | 67.0 (36.0-84.0) | 63.5 (51.0-69.0) |
eGFR (mL/min) | 90.0 (30.0-111.7) | 93.0 (77.0-109.0) |
FIB-4 | 3.0 (0.5-18.3) | 3.7 (1.5-9.0) |
AST (IU/L) | 44.0 (17.0-180.0) | 70.0 (28.0-103.0) |
ALT (IU/L) | 45.0 (12.0-268.0) | 53.5 (35.0-171.0) |
Albumin (mg/dL) | 4.2 (3.0-4.8) | 4.3 (3.3-4.6) |
Total bilirubin (mg/dL) | 0.8 (0.3-2.2) | 0.6 (0.3-1.0) |
PLT (n/μL) | 141000 (13500-312000) | 132000 (71000-229000) |
WBC (cells/μL) | 5560 (2220-11500) | 6245 (2790-9200) |
HCV-RNA (copies/mL) | 776500 (90100-19500000) | 2330000 (793000-3250000) |
- Citation: Strazzulla A, Coppolino G, Di Fatta C, Giancotti F, D’Onofrio G, Postorino MC, Mazzitelli M, Mammone SV, Gentile I, Rivoli L, Palella E, Gravina T, Costa C, Pisani V, De Maria V, Barreca GS, Marascio N, Focà A, Fuiano G, Gulletta E, Torti C. Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? World J Hepatol 2016; 8(19): 815-824
- URL: https://www.wjgnet.com/1948-5182/full/v8/i19/815.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i19.815